About Raichem
Raichem is a Healthcare company. Pharmaceutical manufacturing of APIs, intermediates, and related chemicals in India. It operates in the Healthcare and Chemicals & Materials sectors. The company has 210 employees. Its Indian entity Raichem Medicare Private Limited reported revenue of ₹515 Cr. Raichem offers products and services including Ursodeoxycholic Acid (UDCA) and Intermediates. Its focus areas include Pharmaceuticals, API Manufacturing, Bile Acid Derivatives and Chemicals.
Company details
Raichem, an ICE Pharma Company, was established in 2009 in India with a focus on producing ursodeoxycholic acid and its intermediates. The facility is situated in Raichur, Karnataka, and has been certified with ISO 50001, ISO 9001, ISO 14001, and ISO 45001 standards. Manufacturing processes are supported by RD activities that emphasize the development of generic APIs and improvements in bile acid chemistry. Corporate social responsibility policies are implemented to ensure environmental care and employee safety, while products are supplied to markets in India and Southeast Asia.
- Employees 210
- SectorsHealthcareChemicals & Materials
- Email••••••••
- Phone•••• ••••
- Legal Name Raichem Medicare Private Limited
- Date of Incorporation 01 Jun, 2009
- Jurisdiction Chicksugur Village, Karnataka, India
- Indian entity revenue₹515 Cr
FY 2025 · -12% YoY
- Indian entity net profit₹19.44 Cr
FY 2025 · 4% margin
- Indian entity EBITDA₹52.22 Cr
FY 2025 · 10% margin
- Employee Count210
Associated legal entities of Raichem
Raichem operates through Raichem Medicare Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Raichem Medicare Private Limited CIN U24232KA2009PTC049999 | Active | 01 Jun 2009 | Raichur, Karnataka | ₹515 Cr | 210 | 2 | View details |
Products & Services of Raichem
Raichem offers a comprehensive portfolio of products and services, including Ursodeoxycholic Acid (UDCA) and Intermediates.
Ursodeoxycholic acid is utilized for the treatment of primary biliary cirrhosis and gallstone dissolution in patients with functioning gallbladders.
Intermediates for UDCA production are manufactured and supplied for pharmaceutical applications, supporting the synthesis of bile acid derivatives.
Board of directors of Raichem Medicare Private Limited (Raichem)
Raichem Medicare Private Limited is the primary company behind Raichem. The board of Raichem Medicare Private Limited currently have 2 directors; the longest-serving is Enzo Bartoli, appointed in 2012. 17 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Enzo Bartoli DIN 02981898 | Director | 30 Jan 2012 | 14 yrs 9 mo | Raichem Medicare Private Limited |
| Agostino Barazza DIN 08830494 | Director | 02 Sep 2020 | 6 yrs 1 mo | Raichem Medicare Private Limited |
People of Raichem
21 people are tracked at Raichem (13 in leadership, 6 in board & advisors, 2 in team); the tracked headcount is 210.
| Name | Role | Group |
|---|---|---|
Rajkumar Somani | Vice President Of Business Development | Leadership |
K. H. Honneshaiah | Head of Operations, API | Leadership |
Vishnukant C. Bhutada | Managing Director | Leadership |
Alpesh Dalal | CFO | Leadership |
V. Prakash | SVP, Global Business Head, API Business | Leadership |
Sharath Reddy | VP, Projects & Operations | Leadership |
Arunava Roy | Vice President - Bd- Europe (api And Fdf) | Leadership |
Monish Shah | Head - Strategy And Investor Relations | Leadership |
Pramod Tikane | Assistant General Manager | Leadership |
Karthikeyan Rajakumar | Vice President Supply Chain | Leadership |
Keshav Bhutada | Director | Leadership |
Dr. Jayant Karajgi | COO | Leadership |
Alok Sharma | Head - Associate Vice President - APAC | Leadership |
Sharatha Reddy | Director | Board & advisors |
Arvind Vasudeva | Director | Board & advisors |
Hetal Madhukant Gandhi | Director | Board & advisors |
Kishore Sharma | Director | Board & advisors |
Anita Bandyopadhyay | Director | Board & advisors |
Omprakash Inani | Chairman | Board & advisors |
Sagar Innani | Promoter | Team |
1 more people are available in the full profile.
Complete people profiles for Raichem
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Raichem
Figures of Raichem Medicare Private Limited, the primary company behind Raichem, for FY 2025. Revenue was ₹515 Cr (-12% year on year). Net profit was ₹19.44 Cr (4% margin). EBITDA was ₹52.22 Cr (10% margin). Revenue has grown at a compounded annual rate of +5% over three years and +12% over five years.
- ₹515 CrRevenue · FY 2025 · -12% YoY
- ₹19.44 CrNet profit · 4% margin
- ₹52.22 CrEBITDA · 10% margin
- ₹1.74 CrPaid-up capital
- 210Employees (provident fund records)
- +5%Revenue CAGR, 3 years
- +12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Raichem Medicare Private Limited are on its company page.
Detailed financial statements for Raichem
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Raichem
Raichem has 210 employees.
The primary company behind Raichem, Raichem Medicare Private Limited, reported revenue of ₹515 Cr for FY 2025, down 12% year on year.
Raichem, an ICE Pharma Company, was established in 2009 in India with a focus on producing ursodeoxycholic acid and its intermediates. The facility is situated in Raichur, Karnataka, and has been certified with ISO 50001, ISO 9001, ISO 14001, and ISO 45001 standards. Manufacturing processes are supported by RD activities that emphasize the development of generic APIs and improvements in bile acid chemistry. Corporate social responsibility policies are implemented to ensure environmental care and employee safety, while products are supplied to markets in India and Southeast Asia.
Raichem offers Ursodeoxycholic Acid (UDCA) and Intermediates.
Raichem operates through Raichem Medicare Private Limited.
The legal entities of Raichem currently have 2 directors, including Agostino Barazza, Enzo Bartoli.